These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 31350594)

  • 21. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis.
    Chen M; Masaki T; Sawamura T
    Pharmacol Ther; 2002 Jul; 95(1):89-100. PubMed ID: 12163130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic vasculopathy and the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1).
    Renie G; Maingrette F; Li L
    Curr Diabetes Rev; 2007 May; 3(2):103-10. PubMed ID: 18220661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease.
    Akhmedov A; Sawamura T; Chen CH; Kraler S; Vdovenko D; Lüscher TF
    Eur Heart J; 2021 May; 42(18):1797-1807. PubMed ID: 36282110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation.
    Xu S; Liu Z; Huang Y; Le K; Tang F; Huang H; Ogura S; Little PJ; Shen X; Liu P
    Transl Res; 2012 Aug; 160(2):114-24. PubMed ID: 22677363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis.
    Di Pietro N; Formoso G; Pandolfi A
    Vascul Pharmacol; 2016 Sep; 84():1-7. PubMed ID: 27256928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ROCK2 associates with lectin-like oxidized LDL receptor-1 and mediates oxidized LDL-induced IL-8 production.
    Mattaliano MD; Wooters J; Shih HH; Paulsen JE
    Am J Physiol Cell Physiol; 2010 May; 298(5):C1180-7. PubMed ID: 20181930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lectin-like Oxidized Low-Density Lipoprotein (LDL) Receptor (LOX-1): A Chameleon Receptor for Oxidized LDL.
    Zeya B; Arjuman A; Chandra NC
    Biochemistry; 2016 Aug; 55(32):4437-44. PubMed ID: 27419271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The discovery of LOX-1, its ligands and clinical significance.
    Yoshimoto R; Fujita Y; Kakino A; Iwamoto S; Takaya T; Sawamura T
    Cardiovasc Drugs Ther; 2011 Oct; 25(5):379-91. PubMed ID: 21805404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential pathological roles for oxidized low-density lipoprotein and scavenger receptors SR-AI, CD36, and LOX-1 in aortic valve stenosis.
    Syväranta S; Alanne-Kinnunen M; Oörni K; Oksjoki R; Kupari M; Kovanen PT; Helske-Suihko S
    Atherosclerosis; 2014 Aug; 235(2):398-407. PubMed ID: 24929820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1.
    Cimmino G; Cirillo P; Conte S; Pellegrino G; Barra G; Maresca L; Morello A; Calì G; Loffredo F; De Palma R; Arena G; Sawamura T; Ambrosio G; Golino P
    Cardiovasc Res; 2020 May; 116(6):1125-1135. PubMed ID: 31504248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The oxidized low-density lipoprotein receptor mediates vascular effects of inhaled vehicle emissions.
    Lund AK; Lucero J; Harman M; Madden MC; McDonald JD; Seagrave JC; Campen MJ
    Am J Respir Crit Care Med; 2011 Jul; 184(1):82-91. PubMed ID: 21493736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Ox-LDL and LOX-1 in Atherogenesis.
    Kattoor AJ; Kanuri SH; Mehta JL
    Curr Med Chem; 2019; 26(9):1693-1700. PubMed ID: 29737246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.
    Mehta JL
    Can J Cardiol; 2004 Aug; 20 Suppl B():32B-36B. PubMed ID: 15309203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?
    Chen XP; Zhang TT; Du GH
    Cardiovasc Drug Rev; 2007; 25(2):146-61. PubMed ID: 17614937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway.
    Zhao W; Ma G; Chen X
    Vascul Pharmacol; 2014 Dec; 63(3):162-72. PubMed ID: 25135647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRP is a novel ligand for the oxidized LDL receptor LOX-1.
    Shih HH; Zhang S; Cao W; Hahn A; Wang J; Paulsen JE; Harnish DC
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1643-50. PubMed ID: 19252093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipopolysaccharide augments the uptake of oxidized LDL by up-regulating lectin-like oxidized LDL receptor-1 in macrophages.
    Hossain E; Ota A; Karnan S; Takahashi M; Mannan SB; Konishi H; Hosokawa Y
    Mol Cell Biochem; 2015 Feb; 400(1-2):29-40. PubMed ID: 25348362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protamine may have anti-atherogenic potential by inhibiting the binding of oxidized-low density lipoprotein to LOX-1.
    Takemura Y; Okamoto M; Hasegawa M; Hatanaka K; Kubota S
    Biosci Biotechnol Biochem; 2019 Jun; 83(6):1094-1101. PubMed ID: 30871430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis].
    Morawietz H
    Dtsch Med Wochenschr; 2010 Feb; 135(7):308-12. PubMed ID: 20146162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LOX-1: a critical player in the genesis and progression of myocardial ischemia.
    Lü J; Mehta JL
    Cardiovasc Drugs Ther; 2011 Oct; 25(5):431-40. PubMed ID: 21847544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.